🇺🇸 FDA

Intelligence · Patent portfolio

S.L Patents

Full USPTO pharma patent portfolio for S.L — grant dates, expiration, and drug cross-links.

Patents
179
Expiring ≤24m
16

Quick answer

S.L has 179 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 16 expire within 24 months — use filters for patent-cliff planning.

Page 2 of 4

  1. US 9790158

    Substituted tropolone derivatives and methods of use

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9783616

    Regulating transplant rejection of donor and embryonic stem cell-derived tissues and organs

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9725698

    Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9669076

    Albumin-free factor VIII formulations

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9657023

    Polymorph of Syk inhibitors

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9650365

    Itraconazole analogues and methods of use thereof

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9636424

    Composition, method, system and kit for optical electrophysiology

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9567348

    Substituted pyrazolo[1,5-a]pyrimidines as Syk inhibitors

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9566348

    Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9562056

    Imidazopyridines Syk inhibitors

    Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9505785

    Pyridone and aza-pyridone compounds and methods of use

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9414599

    Process for the preparation of a metal complex in an oily organic matrix

    Expires Mon Aug 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9382213

    Heterocyclic and cyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9382256

    Formulation of Syk inhibitors

    Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9371368

    Compositions and methods for immunomodulation in an organism

    Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9365630

    Compositions and methods for Immunomodulation in an organism

    Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9357924

    Composition, method, system and kit for optical electrophysiology

    Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9352019

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9352027

    Albumin-free factor VIII formulations

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9353175

    Use of antagonists targeting metallothionein to treat intestinal inflammation

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9303053

    Compositions and methods to treat cardiac diseases

    Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9247910

    Artificial tissue systems and uses thereof

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9248172

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9249123

    Pyridinones/pyrazinones, method of making, and method of use thereof

    Expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9212191

    6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitor

    Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9120811

    6-(1H-indazol-6-YL)-N-(4-morpholinophenyl)imidazo[1,4-A]pyrazin-8-amine for treating leukemia or lymphoma

    Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9101575

    Methods of inhibiting vascular permeability and apoptosis

    Expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9078832

    Biomimetic scaffold for bone regeneration

    Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8975260

    Pyridazinones, method of making, and method of use thereof

    Expires Mon Mar 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8962835

    Imidazopyrazine Syk inhibitors

    Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8945635

    Formulations comprising extracts from primitive plant species (mosses, ferns and lichens) to treat and prevent cancers

    Expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8940288

    Method for treating cancer by administering IL-15 and IL-15Ralpha complexes

    Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8927275

    Differentiation of human embryonic and induced pluripotent stem cells

    Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8916184

    Artificial tissue systems and uses thereof

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8877204

    Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes

    Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8853205

    Heteropyrrole analogs acting on cannabinoid receptors

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8853228

    Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8796270

    N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor

    Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8785191

    Concentration of stem cells obtained during orthopaedic surgeries

    Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8765761

    6-(1H-indazol-6-yl)-N-{4-[2-methyl-1-(morpholin-4-yl)propan-2-yl]phenyl}imidazo[1,2-A]pyrazin-8-amine, or a pharmaceutically acceptable salt thereof, as a syk inhibitor

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8765665

    Albumin-free factor VIII formulations

    Expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8748607

    Imidazopyrizine syk inhibitors

    Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8697699

    Imidazopyrazine SYK inhibitors

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8637506

    Compositions and methods for bone formation and remodeling

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8618107

    Pyridone and aza-pyridone compounds and methods of use

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8614189

    Carbon nanotube composite scaffolds for bone tissue engineering

    Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8598174

    Pyridazinones, method of making, and method of use thereof

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8591890

    Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

    Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does S.L have?

179 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do S.L patents expire?

16 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.